Open AccessWITHDRAWAL OF MYCOPHENOLATE MOFETIL IN STABLE RENAL TRANSPLANT RECIPIENTS
Author(s) -
Bruce Kaplan,
Herwig Ulf Meier-Kriesche,
Mahesh Vaghela,
Gary S. Friedman,
Shamkant Mulgaonkar,
Martin Jacobs
Publication year - 2000
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200004270-00034
Subject(s) - medicine , prednisone , mycophenolate , mycophenolic acid , transplantation , renal transplant , creatinine , urology , incidence (geometry) , kidney transplantation , proteinuria , gastroenterology , surgery , kidney , physics , optics
Mycophenolate mofetil (MMF) has been demonstrated to decrease episodes of acute rejection in renal transplant recipients during the first year after transplantation. The utility of MMF after 1 year is less clear.